- STAT+: Anthropic deepens work with rare disease drugsNovo Nordisk sues Eli Lilly over GLP-1s, Medicare pricing plans, and more biotech news from The ReadoutSTAT · 3d ago↗ source
- STAT+: Pharmalittle: We’re reading about Novo suing Lilly over ‘deceptive’ ads, a fugitive’s secret life in biotech, and moreNovo Nordisk sued Eli Lilly for allegedly running “deceptive” ads to make its obesity and diabetes drugs appear more effectiveSTAT · 3d ago↗ source
- Novartis stays 'geography-agnostic' in dealmaking amid flurry of China dealsNovartis will continue to be on the lookout for bolt-on deals below $2 billion, CEO Vas Narasimhan said Tuesday on the pharma's second quarter earnings call—though major pickups aren’t completely o…